Pius S. Hornstein, Head of China, General Medicines and China Country Lead of Sanofi

As a healthcare leader, Sanofi demonstrated its solidarity with the Chinese government and people in combating the epidemic and supporting China's economy. We took prompt actions to donate 1.5 million yuan for medical devices and protective supplies, and restarted our 3 manufacturing sites in a timely manner to ensure supply continuity of high-quality medicines and vaccines for Chinese people.

While experts estimate China's economy could be hit in the short run due to the epidemic, we remain confident the country has the ability and means to get back rapidly to its growth trajectory. From the Sanofi side, we have worked closely with authorities to ensure we were able to open our factories right from the start, to ensure supply of our key medicines. In healthcare, we can expect this crisis to result in further investments in this area, and potentially reshape the healthcare ecosystem.

Sanofi is aligned with the national "Healthy China 2030" agenda, supporting the Chinese government's five healthcare priorities and focusing on the prevention and control of five major diseases, and will accelerate the research and introduction of new products. We have full confidence China will continue to play a key role as an engine to the world economy based on its strengths, scale and agility. Building on its unique strengths in digital capabilities which are already existing, China is expected to further boost the digital models and become a pioneer of a successful, more digitalized economy.